USD 98.50 Million
Report ID:
SQMIG35I2140 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
91
|Figures:
76
Global 3D Printed Drugs Market size was valued at USD 84.9 Million in 2022 and is poised to grow from USD 98.50 Million in 2023 to USD 322.91 Million by 2031, at a CAGR of 16% during the forecast period (2024-2031).
The global 3D Printed Drugs market is a rapidly growing sector in the pharmaceutical industry. 3D printing technology is being increasingly used to create customized drug formulations, which can improve drug efficacy, reduce side effects, and provide personalized dosing. The 3D printing process involves creating a three-dimensional object by laying down successive layers of material, and in the case of drug manufacturing, this involves printing precise doses of drugs onto a substrate. North America dominates the market, followed by Europe and Asia Pacific. The growth of the market can be attributed to the increasing demand for personalized medicines, the ability of 3D printing to provide precise dosing and reduce side effects, and advancements in technology. The purpose of the 3D printed drugs market is to provide a new and innovative way of manufacturing drugs that can improve patient outcomes and reduce healthcare costs. The use of 3D printing technology in drug manufacturing can provide greater flexibility in drug design, reduce waste, and allow for the production of drugs on demand. The major driving factors for the growth of the 3D printed drugs market include increasing demand for personalized medicines, advancements in technology, the ability of 3D printing to provide precise dosing and reduce side effects, and the need to reduce healthcare costs. The major restraining factors for the growth of the 3D printed drugs market include the high cost of 3D printing technology and regulatory challenges associated with the approval of 3D printed drugs. The challenges in the 3D printed drugs market include the need for further research and development to ensure the safety and efficacy of 3D printed drugs, the need for standardization of 3D printing processes, and the potential for intellectual property disputes. The opportunities in the 3D printed drugs market include the development of new and innovative drug formulations, the expansion of the market to new regions, and the potential for 3D printing to transform drug delivery and personalized medicine. The use of 3D printing technology in drug manufacturing could also provide new revenue streams for pharmaceutical companies.
Global Market Size
USD 98.50 Million
Largest Segment
Zip Dose Technology
Fastest Growth
Inkjet Printing
Growth Rate
16% CAGR
To get more reports on the above market click here to Buy The Report
The global 3D printed drugs market is segmented based on dosage form, technology, application, and region. Based on technology, the market is segmented into Inkjet Printing, Direct Write, Zip Dose, Thermal Inkjet Printing, Fused Deposition Modelling, Powder Bed Printing, Stereolithography (SLA) and Semi Solid Extrusion (SSE). Based on application, the market is segmented into orthopedics, neurology, dental, and others. Based on dosage form, the market is segmented into Tablet, Capsule, Multidrug Implant, Nanoparticles, Solutions and Other Products. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and MEA.
Analysis by Technology
In the realm of 3D printing, Fused Deposition Modeling (FDM) now reigns supreme as the largest and quickest segment. FDM printers are comparatively inexpensive, easy to use, and able to create a large variety of items since they employ spools of molten filament that are deposited layer by layer. Although there are more precise technologies like as Stereolithography (SLA), FDM is faster and more accessible, which makes it a popular choice for designers, amateurs, and even small-scale production applications.
Analysis by Application
In 2023, the neurology section held a 49.84% market share, making it the dominant segment. The SPRITAM (levetiracetam) pills made by Aprecia Pharmaceutical were authorised by the FDA in August 2015 for the treatment of epilepsy. There isn't a single medicine that has been authorised and is sold. Pharmaceutical firms are now interested in investing in this market sector as a result of this clearance, which is driving the market's expansion.
However, orthopaedic treatments are difficult and complex, and new methods are required to address several identified problems and improve patient outcomes. Furthermore, problems often lead to prolonged patient suffering and loss of function, especially given the high likelihood of infection. Orthopaedic medications can therefore be used to prevent postoperative infections, which will fuel market expansion.
Analysis by Dosage
The most widely used and fastest-growing 3D printing method for medicine delivery is dosage segmentation in tablets and capsules. This is likely caused by many things, such as the fact that these dosage forms are well-known and simple to use, and that the printing settings allow for exact control over the drug's dosage and release profile.
To get detailed analysis on other segments, Request For Free Sample Report
With a 37.23% share in the regional market in 2022, North America was in the lead. This significant portion is explained by a number of factors, including a rise in the prevalence of chronic illnesses, a strong domestic healthcare system, significant R&D spending, and the growing application of technical advancements in the North American area.
Because of the notable advancements made by China and Japan in the technical integration of 3D printed medicine techniques, the Asia Pacific area is predicted to expand at the highest rate. Additionally, growing nations like Australia and India are developing their clinical development frameworks, R&D, and healthcare infrastructure, which is positioning the Asia Pacific market for growth and profitable prospects over the course of the projected period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
The increasing demand for personalized medicines is a major driver of the global 3D Printed Drugs market. Personalized medicines are drugs that are tailored to the individual patient based on their genetics, environment, and lifestyle. These drugs offer several advantages over traditional drugs, including improved efficacy, reduced side effects, and increased patient compliance. 3D printing technology enables the creation of customized drug formulations with precise dosing and drug release characteristics, making it an ideal technology for the production of personalized medicines. With 3D printing, pharmaceutical companies can create drugs with unique geometries and formulations that cannot be achieved using traditional manufacturing methods. The demand for personalized medicines is increasing due to the rising prevalence of chronic diseases and the need for targeted drug delivery. Chronic diseases such as cancer, diabetes, and cardiovascular diseases require long-term treatment and personalized medicines can improve patient outcomes and quality of life. Additionally, targeted drug delivery can reduce the dose required, reducing side effects and improving patient compliance. The global 3D Printed Drugs market is expected to grow significantly in the coming years. With the increasing demand for personalized medicines and advancements in 3D printing technology, the global 3D Printed Drugs market is expected to continue to grow at a rapid pace.
Major advancements in technology is another major driver of the global 3D printed drugs market. Over the years, 3D printing technology has advanced significantly, enabling the creation of more complex and precise drug formulations. 3D printing technology has advanced to the point where it can create drugs with precise dosing and release characteristics. This level of precision enables pharmaceutical companies to create drugs that are tailored to individual patients, improving efficacy and reducing side effects. Advances in 3D printing technology have led to faster production times for 3D Printed Drugs. This has reduced the time required for drug development and manufacturing, allowing pharmaceutical companies to bring new drugs to market more quickly. 3D printing technology has expanded beyond the use of traditional plastics and metals to include a wide range of materials. This includes biocompatible materials that can be used for drug delivery, such as hydrogels and polymers.
Restraints
The initial investment required for 3D printing equipment, software, and materials can be significant, making it difficult for small and medium-sized pharmaceutical companies to adopt the technology. The cost per unit of 3D printed drugs can be higher than traditional drugs due to the high cost of materials and the time required for production. This can make 3D printed drugs less affordable for patients, reducing demand for the products. The regulatory framework for 3D printed drugs is still developing, and regulatory approval can be a lengthy and expensive process. This can further increase the cost of 3D printed drugs and limit their accessibility to patients.
The development of 3D Printed Drugs is a relatively new technology, and regulatory authorities are still developing guidelines for the approval and regulation of these products. The lack of clear regulatory guidelines can make it difficult for pharmaceutical companies to develop and bring 3D Printed Drugs to market. The regulatory approval process for 3D Printed Drugs can be lengthy and expensive, which can further delay the availability of these products to patients. The lack of regulatory harmonization between different regions and countries can also make it difficult for companies to obtain approvals in different markets. There may be concerns about the quality and safety of 3D Printed Drugs. Regulatory challenges are a significant restraint for the global 3D Printed Drugs market, and it may slow down the adoption of this technology. It is expected that the regulatory challenges will be reduced, and the market for 3D Printed Drugs will continue to grow.
Request Free Customization of this report to help us to meet your business objectives.
The global 3D printed drugs market is very competitive in nature owing to various strategies including partnerships through geographical expansion, mergers and acquisitions, and strategic collaborations to expand their market presence. The business manufactures a variety of prescription drugs and vaccinations. The pharmaceutical industry finds, creates, and sells drugs to treat both acute and chronic illnesses. The vaccines industry offers vaccinations for individuals of all ages, from infants and adolescents to adults and senior citizens. Its product line includes HIV and respiratory medications. Respiratory, HIV, Specialty Products, and Classic and Established Products are all part of its pharmaceuticals division. Over 40 vaccinations for children, adolescents, adults, older adults, and travellers are included in the company's vaccine portfolio.
3D Printed Drugs Market Top Player’s Company Profiles
3D Printed Drugs Market Recent Developments
In February 2024, 3D-Printed Microbes Produce Plant-Based Chemicals.
In February 2024, Cutting-edge technologies can transform India into a global pharma powerhouse.
In October 2023, Crucify launches GMP Pharma inks for on-site 3D printing of personalized medicines.
In September 2021, Merck announced that it had successfully 3D printed a tablet with multiple layers, which could release different drugs at different times, opening up new possibilities for personalized medicine.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, The Global 3D Printed Drugs Market is expected to experience significant growth during the forecast period from 2022 to 2030. The global 3D Printed Drugs market refers to the market for pharmaceuticals that are manufactured using 3D printing technology. 3D printing, also known as additive manufacturing, involves the layer-by-layer creation of three-dimensional objects using a digital model. The technology has the potential to revolutionize the pharmaceutical industry by allowing for the customization of drugs to meet specific patient needs. The market for 3D printed drugs is expected to grow significantly in the coming years. The market is driven by the increasing demand for personalized medicine, as well as the benefits of 3D printing in drug development, such as the ability to produce complex drug formulations with precise dosing. The global 3D printed drugs market is a growing market with significant potential for growth in the coming years. The market is driven by the increasing demand for personalized medicine and the benefits of 3D printing technology in drug development.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 84.9 Million |
Market size value in 2031 | USD 322.91 Million |
Growth Rate | 16% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the 3D Printed Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the 3D Printed Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the 3D Printed Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the 3D Printed Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2140